0000000000658544

AUTHOR

M. Musso

showing 4 related works from this author

OUTCOME OF CYTOGENETICS IN PATIENTS WITH NEWLY DIAGNOSED EXTRAMEDULLARY MYELOMA UNDERGOING STEM-CELL TRANSPLANTATION

2018

[SDV.CAN] Life Sciences [q-bio]/Cancer
researchProduct

Bone marrow granulomas in hairy cell leukaemia following 2-chlorodeoxyadenosine therapy

1994

AdultMalePathologymedicine.medical_specialtyHistologymedicine.medical_treatmentPathology and Forensic MedicineBONE MARROW GRANULOMASBone MarrowChlorodeoxyadenosineHumansMedicineBone Marrow DiseasesLeukemia Hairy CellChemotherapyGranulomabusiness.industryHairy cell leukaemiaGeneral Medicinemedicine.diseaseLeukemiamedicine.anatomical_structureCladribineImmunohistochemistryBone marrowbusinessEpithelioid cellHistopathology
researchProduct

Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in pati…

2012

Summary Von Willebrand disease (VWD) is an inherited bleeding disorder caused by the quantitative or qualitative deficiency of von Willebrand factor (VWF). Replacement therapy with plasma-derived VWF/factor VIII (FVIII) concentrates is required in patients unresponsive to desmopressin. To assess the efficacy, safety and ease of use of a new, volume-reduced (VR) formulation of VWF/FVIII concentrate Haemate® P in patients requiring treatment for bleeding or prophylaxis for recurrent bleeding or for invasive procedures. Pharmacoeconomic variables were also recorded. Data were analysed using descriptive statistics. This was a multicentre, prospective, observational study. Consecutively enrolled…

AdultMalePediatricsmedicine.medical_specialtyAdolescentBlood Loss SurgicalSevere diseaseHemorrhageSettore MED/15 - Malattie Del SangueYoung AdultVon Willebrand factorCost of Illnesshemic and lymphatic diseaseshemophiliavon Willebrand FactorVon Willebrand diseasemedicineHumansIn patientProspective StudiesDesmopressinAdverse effectChildGenetics (clinical)AgedFactor VIIIbiologybusiness.industryDrug SubstitutionAnticoagulantsHematologyGeneral MedicineMiddle Agedmedicine.diseaseResponse to treatmentHospitalizationvon Willebrand DiseasesItalyChild Preschoolbiology.proteinPasteurizationObservational studyFemalebusinessmedicine.drug
researchProduct

BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RE…

2010

Bendamustinechronic lymphocytic leukemiaSettore MED/15 - Malattie Del Sangue
researchProduct